FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Barbara Kuter

Research Profile

Chemicals & Drugs

Living Beings

Disorders

Concepts & Ideas

Immunization Schedule

Procedures

Co-author Network

Publications

TOP 3
Michael Leonardi; Ouzama Nicholson; James Trammel; Wendy Williams; Roger Baxter; Michael Brockley; Kenneth Bromberg; Julie L Gardner; Stephanie Klopfer; Barbara J Kuter; Vicky Leamy; Florian Schodel
Immunogenicity and safety of MMRV and PCV-7 administered concomitantly in healthy children.
Henry Shinefield; Steve Black; Barbara J Kuter
Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
Joseph F Heyse; Barbara J Kuter; Michael J Dallas; Penny M Heaton
Evaluating the safety of a rotavirus vaccine: the REST of the story.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Barbara Kuter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Michael Leonardi; Ouzama Nicholson; James Trammel; Wendy Williams; Roger Baxter; Michael Brockley; Kenneth Bromberg; Julie L Gardner; Stephanie Klopfer; Barbara J Kuter; Vicky Leamy; Florian Schodel
Immunogenicity and safety of MMRV and PCV-7 administered concomitantly in healthy children.
Pediatrics 2011;128(6):e1387-94.
2008: Henry Shinefield; Steve Black; Barbara J Kuter
Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
The Journal of infectious diseases 2008;197 Suppl 2():S152-5.
2008: Joseph F Heyse; Barbara J Kuter; Michael J Dallas; Penny M Heaton
Evaluating the safety of a rotavirus vaccine: the REST of the story.
Clinical trials (London, England) 2008;5(2):131-9.
2007: Jeffrey L Silber; Ivan S F Chan; William W Wang; Holly Matthews; Barbara J Kuter
Immunogenicity of Oka/Merck varicella vaccine in children vaccinated at 12-14 months of age versus 15-23 months of age.
The Pediatric infectious disease journal 2007;26(7):572-6.
2007: Henry H Bernstein; Karen A Eves; Kristy Campbell; Steven B Black; Jerry D Twiggs; Keith S Reisinger; Ralph M Conti; Carl-Erik Flodmark; Lars Rombo; Stephanie Klopfer; Florian Schodel; Jonathan Hartzel; Barbara J Kuter
Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live).
Pediatrics 2007;119(6):e1299-305.
2006: Gabriele Jäger; Barbara J Kuter; Hartmut Campe; Hassan Lakkis; Hans Nitschko; Michael Watson; Erika Harzer; Florian Schodel
large-scale serologic testing program to assess the immunogenicity of inactivated hepatitis a vaccine (VAQTA) in prefilled syringes following product recall in Germany.
Human vaccines 2006;2(6):233-6.
2006: Fernando A Guerra; Jacqueline O Gress; Alan Werzberger; Keith S Reisinger; Emmanuel Walter; Hassan D Lakkis; Anthony D Grosso; Carolee Welebob; Barbara J Kuter
Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children.
The Pediatric infectious disease journal 2006;25(10):912-9.
2006: Barbara J Kuter; Michelle L Hoffman Brown; Jonathan Hartzel; Wendy R Williams; A EvesiKaren; Steve Black; Henry Shinefield; Keith S Reisinger; Colin D Marchant; Bradley J Sullivan; Marci Thear; Stephanie Klopfer; Jin Xu; Jacqueline O Gress; Florian Schodel
Safety and immunogenicity of a combination measles, mumps, rubella and varicella vaccine (ProQuad).
Human vaccines 2006;2(5):205-14.
2006: Jay M Lieberman; Wendy R Williams; Jacqueline M Miller; Steve Black; Henry Shinefield; Frederick W Henderson; Colin D Marchant; Alan Werzberger; Scott Halperin; Jonathan Hartzel; Stephanie Klopfer; Florian Schodel; Barbara J Kuter
The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
The Pediatric infectious disease journal 2006;25(7):615-22.
2006: Henry Shinefield; Steve Black; Marci Thear; Daniel Coury; Keith S Reisinger; Edward Rothstein; Jin Xu; Jonathan Hartzel; Barbara Evans; Laura Digilio; Florian Schodel; Michelle L Hoffman Brown; Barbara J Kuter
Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
The Pediatric infectious disease journal 2006;25(4):287-92.
2006: Keith S Reisinger; Michelle L Hoffman Brown; Jin Xu; Bradley J Sullivan; Gary S Marshall; Beth Nauert; David O Matson; Peter E Silas; Florian Schodel; Jacqueline O Gress; Barbara J Kuter
A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
Pediatrics 2006;117(2):265-72.
2005: Henry Shinefield; Steve Black; Wendy R Williams; Colin D Marchant; Keith S Reisinger; Tracy Stewart; H Cody Meissner; Juan Guerrero; Stephanie Klopfer; Jin Xu; Florian Schodel; Barbara J Kuter
Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.
The Pediatric infectious disease journal 2005;24(8):670-5.
2005: Henry Shinefield; Steve Black; Laura Digilio; Keith S Reisinger; Mark M Blatter; Jacqueline O Gress; Michelle L Hoffman Brown; Karen A Eves; Stephanie Klopfer; Florian Schodel; Barbara J Kuter
Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.
The Pediatric infectious disease journal 2005;24(8):665-9.
2004: Y M Sohn; J S Lee; J H Park; G Poerschke; Karen A Eves; J Gress; Barbara J Kuter
Immunizing children to protect against the increasing risk of hepatitis A in adolescents and young adults in South Korea.
The Southeast Asian journal of tropical medicine and public health 2004;35(4):954-8.
2004: Hua Wang; X Chen; Zhixian Chen; W Lu; Gabriele Poerschke; Karen A Eves; Jacqueline Gress; Barbara J Kuter
Field performance of VAQTA (inactivated, purified hepatitis a vaccine) in Chinese children in Jiangsu.
The Southeast Asian journal of tropical medicine and public health 2004;35(4):949-53.
2004: Mark R Wallace; Carolyn J Brandt; Kenneth C Earhart; Barbara J Kuter; Anthony D Grosso; Hassan D Lakkis; Sybil A Tasker
Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(8):1207-13.
2004: Barbara J Kuter; Holly Matthews; Henry Shinefield; Steve Black; Penelope H Dennehy; Barbara Watson; Keith S Reisinger; Lee-Lian Kim; Lisa Lupinacci; Jonathan Hartzel; Ivan S F Chan
Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
The Pediatric infectious disease journal 2004;23(2):132-7.
2002: Henry Shinefield; Steven B Black; Brenda O Staehle; Holly Matthews; Tama Adelman; Kathleen Ensor; Shu Li; Ivan S F Chan; Joseph F Heyse; Marilyn Waters; Christina Y Chan; S J Rupert Vessey; Karen M Kaplan; Barbara J Kuter
Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children.
The Pediatric infectious disease journal 2002;21(6):555-61.
2002: Jay M Lieberman; Swei-Ju Chang; Susan Partridge; Jennifer C Hollister; Karen M Kaplan; Erin Jensen; Barbara J Kuter; Joel I Ward
Kinetics of maternal hepatitis a antibody decay in infants: implications for vaccine use.
The Pediatric infectious disease journal 2002;21(4):347-8.
2002: Shu Li; Ivan S F Chan; Holly Matthews; Joseph F Heyse; Christina Y Chan; Barbara J Kuter; Karen M Kaplan; S J Rupert Vessey; Jerald C Sadoff
Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection.
The Pediatric infectious disease journal 2002;21(4):337-42.
2002: Alan Werzberger; Barbara Mensch; David Nalin; Barbara J Kuter
Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTA.
Vaccine 2002;20(13-14):1699-701.
2002: Elaine C Jong; Karen M Kaplan; Karen A Eves; Colleen A Taddeo; Hassan D Lakkis; Barbara J Kuter
An open randomized study of inactivated hepatitis A vaccine administered concomitantly with typhoid fever and yellow fever vaccines.
Journal of travel medicine 2002;9(2):66-70.
2001: Francisco Averhoff; Craig N Shapiro; Beth P Bell; I Hyams; L Burd; Adeline M Deladisma; Edgar Simard; David Nalin; Barbara J Kuter; C Ward; M Lundberg; N Smith; Harold S Margolis
Control of hepatitis A through routine vaccination of children.
JAMA : the journal of the American Medical Association 2001;286(23):2968-73.
2001: RB Hornick; R Tucker; Karen M Kaplan; Karen A Eves; D Banerjee; Erin Jensen; Barbara J Kuter
A randomized study of a flexible booster dosing regimen of VAQTA in adults: safety, tolerability, and immunogenicity.
Vaccine 2001;19(32):4727-31.
2001: S J Rupert Vessey; Christina Y Chan; Barbara J Kuter; Karen M Kaplan; M Waters; D P Kutzler; P A Carfagno; Jerald C Sadoff; Joseph F Heyse; Holly Matthews; Shu Li; Ivan S F Chan
Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy.
The Journal of pediatrics 2001;139(2):297-304.
2001: T Linglöf; J van Hattum; Karen M Kaplan; J Corrigan; I Duval; Erin Jensen; Barbara J Kuter
An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA) in adults: safety, tolerability, and immunogenicity.
Vaccine 2001;19(28-29):3968-71.
2001: Bradley A Connor; J Phair; David A Sack; D McEniry; RB Hornick; D Banerjee; Erin Jensen; Barbara J Kuter
Randomized, double-blind study in healthy adults to assess the boosting effect of Vaqta or Havrix after a single dose of Havrix.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(3):396-401.
2000: L Su; R Tucker; S E Frey; Jacqueline O Gress; Ivan S F Chan; Barbara J Kuter; Harry A Guess
Measuring injection-site pain associated with vaccine administration in adults: a randomised, double-blind, placebo-controlled clinical trial.
Journal of epidemiology and biostatistics 2000;5(6):359-65.
1998: Henry Shinefield; Steven B Black; Brenda O Staehle; T Adelman; Kathleen Ensor; AL Ngai; CJ White; S R Bird; Holly Matthews; Barbara J Kuter
Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX.
The Pediatric infectious disease journal 1998;17(11):980-5.
1998: A Werzberger; Barbara J Kuter; David Nalin
Six years' follow-up after hepatitis A vaccination.
The New England journal of medicine 1998;338(16):1160.
1997: PD Reuman; M H Sawyer; Barbara J Kuter; Holly Matthews
Safety and immunogenicity of concurrent administration of measles-mumps-rubella-varicella vaccine and PedvaxHIB vaccines in healthy children twelve to eighteen months old. The MMRV Study Group.
The Pediatric infectious disease journal 1997;16(7):662-7.
1997: CJ White; D Stinson; Brenda O Staehle; Iksung Cho; Holly Matthews; AL Ngai; P Keller; J Eiden; Barbara J Kuter
Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(5):925-31.
1996: B L Wiens; N R Bohidar; J G Pigeon; J Egan; William M Hurni; L Brown; Barbara J Kuter; D R Nalin
Duration of protection from clinical hepatitis A disease after vaccination with VAQTA.
Journal of medical virology 1996;49(3):235-41.
1996: B M Watson; D S Laufer; Barbara J Kuter; B Staehle; C J White; Stuart E Starr
Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children.
The Journal of infectious diseases 1996;173(3):731-4.
1996: A L Ngai; B O Staehle; Barbara J Kuter; N M Cyanovich; Iksung Cho; Holly Matthews; P Keller; A M Arvin; B Watson; C J White
Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children.
The Pediatric infectious disease journal 1996;15(1):49-54.
1995: Barbara J Kuter; A Ngai; C M Patterson; B O Staehle; Iksung Cho; Holly Matthews; P J Provost; C J White
Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group.
Vaccine 1995;13(11):967-72.
1993: B Watson; S Piercy; D Soppas; K Browngoehl; M Warner; K Isganitis; C J White; Barbara J Kuter; J Chua; S Starr
The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka/Merck varicella vaccine.
The Journal of infectious diseases 1993;168(6):1356-60.
1993: W J Miller; W Clark; William M Hurni; Barbara J Kuter; Timothy L Schofield; D Nalin
Sensitive assays for hepatitis A antibodies.
Journal of medical virology 1993;41(3):201-4.
1993: Daniel Shouval; Yaffa Ashur; R Adler; J A Lewis; M E Armstrong; J P Davide; B McGuire; Barbara J Kuter; L Brown; W Miller
Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.
Vaccine 1993;11 Suppl 1():S9-14.
1993: D Nalin; L Brown; Barbara J Kuter; C Patterson; B McGuire; A Werzberger; Mathuram Santosham; S Block; Keith S Reisinger; B Watson
Inactivated hepatitis A vaccine in childhood: implications for disease control.
Vaccine 1993;11 Suppl 1():S15-7.
1993: D R Nalin; Barbara J Kuter; L Brown; C Patterson; G B Calandra; A Werzberger; Daniel Shouval; E Ellerbeck; S L Block; R Bishop
Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview.
Journal of hepatology 1993;18 Suppl 2():S51-5.
1993: A Werzberger; Barbara J Kuter; Daniel Shouval; B Mensch; L Brown; B Wiens; J Lewis; W Miller; R Sitrin; P Provost
Anatomy of a trial: a historical view of the Monroe inactivated hepatitis A protective efficacy trial.
Journal of hepatology 1993;18 Suppl 2():S46-50.
1993: Daniel Shouval; Yaffa Ashur; R Adler; J A Lewis; W Miller; Barbara J Kuter; L Brown; D R Nalin
Safety, tolerability, and immunogenicity of an inactivated hepatitis A vaccine: effects of single and booster injections, and comparison to administration of immune globulin.
Journal of hepatology 1993;18 Suppl 2():S32-7.
1992: A Werzberger; B Mensch; Barbara J Kuter; L Brown; J Lewis; R Sitrin; W Miller; Daniel Shouval; B Wiens; G Calandra
A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.
The New England journal of medicine 1992;327(7):453-7.
1992: C J White; Barbara J Kuter; A Ngai; C S Hildebrand; K L Isganitis; C M Patterson; A Capra; W J Miller; D L Krah; P J Provost
Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response.
The Pediatric infectious disease journal 1992;11(1):19-23.
1991: Barbara J Kuter; R E Weibel; Harry A Guess; Holly Matthews; D H Morton; B J Neff; P J Provost; B A Watson; Stuart E Starr; SA Plotkin
Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies.
Vaccine 1991;9(9):643-7.
1991: C J White; Barbara J Kuter; C S Hildebrand; K L Isganitis; Holly Matthews; W J Miller; P J Provost; R W Ellis; R J Gerety; G B Calandra
Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989.
Pediatrics 1991;87(5):604-10.
1991: P J Provost; D L Krah; Barbara J Kuter; D H Morton; Timothy L Schofield; E H Wasmuth; C J White; W J Miller; R W Ellis
Antibody assays suitable for assessing immune responses to live varicella vaccine.
Vaccine 1991;9(2):111-6.
1985: R E Weibel; Barbara J Kuter; B J Neff; C A Rothenberger; A J Fitzgerald; K A Connor; D Morton; A A McLean; E M Scolnick
Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment.
JAMA : the journal of the American Medical Association 1985;254(17):2435-9.
1984: R E Weibel; B J Neff; Barbara J Kuter; Harry A Guess; C A Rothenberger; A J Fitzgerald; K A Connor; A A McLean; M R Hilleman; E B Buynak
Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
The New England journal of medicine 1984;310(22):1409-15.